THOMAS GAZDA: Open Payments
NPI 1730158189 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53,799 in 47 payments from 7 companies in 2025. Trend: 2023 $207,098 · 2024 $117,875 · 2025 $53,799
Speaker / faculty: $28,552Honoraria: $17,613Travel & lodging: $5,870Food & beverage: $1,763
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 26 | $27,153 |
| Axsome Therapeutics, Inc. | 14 | $18,343 |
| Teva Pharmaceuticals USA, Inc. | 3 | $5,833 |
| Luye Pharma (USA) Ltd. | 1 | $1,750 |
| Janssen Pharmaceuticals, Inc | 1 | $585 |
| Braeburn Inc. | 1 | $110 |
| Alkermes, Inc. | 1 | $25 |
Products named: COBENFY, Auvelity, UZEDY, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, BRIXADI, ARISTADA.
Industry payments across AZ — which companies pay providers there.
